Farallon Capital Management LLC Agios Pharmaceuticals, Inc. Put Options Transaction History
Farallon Capital Management LLC
- $22.3 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AGIO
# of Institutions
235Shares Held
61.8MCall Options Held
297KPut Options Held
235K-
Vanguard Group Inc Valley Forge, PA5.68MShares$201 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$172 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.59MShares$127 Million2.72% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.33MShares$82.3 Million0.65% of portfolio
-
Commodore Capital LP New York, NY2.33MShares$82.3 Million7.21% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.94B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...